Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
BiotechStocktrader
-
May 8, 2020
0
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
BiotechStocktrader
-
May 4, 2020
0
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
BiotechStocktrader
-
May 4, 2020
0
CEO Interviews
Home
CEO Interviews
Page 2
Featured posts
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug...
BiotechStocktrader
-
December 14, 2018
0
Citius Pharma (CTXR) Chairman, Leonard Mazur Discusses Progress and Timeline for...
BiotechStocktrader
-
December 11, 2018
0
BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market
BiotechStocktrader
-
October 20, 2018
0
BioSig $BSGM Shows Promise for Investors in One of the Fastest...
BiotechStocktrader
-
November 8, 2017
0
1
2
3
Page 2 of 3
- Advertisement -
LATEST NEWS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Paul Archie
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
Paul Archie
-
December 8, 2020
LATEST INTERVIEWS
